2023
Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022
Klaassen F, Chitwood M, Cohen T, Pitzer V, Russi M, Swartwood N, Salomon J, Menzies N. Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022. Clinical Infectious Diseases 2023, 77: 355-361. PMID: 37074868, PMCID: PMC10425195, DOI: 10.1093/cid/ciad210.Peer-Reviewed Original ResearchConceptsSevere diseasePopulation immunityOmicron infectionOmicron variantUS populationSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2SARS-CoV-2 infectionRespiratory syndrome coronavirus 2SARS-CoV-2 Omicron variantRestoration of immunitySyndrome coronavirus 2Bayesian evidence synthesis modelInfection-acquired immunityEvidence synthesis modelSARS-CoV-2Prior immunological exposureCoronavirus 2Additional infectionsImmunological exposureInfectionDiseaseImmunityVaccinationUnited States
2020
High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000–2016
Hill AN, Cohen T, Salomon JA, Menzies NA. High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000–2016. Epidemics 2020, 33: 100419. PMID: 33242759, PMCID: PMC7808561, DOI: 10.1016/j.epidem.2020.100419.Peer-Reviewed Original ResearchConceptsIncidence risk ratioTuberculosis incidence rateIncidence rateTuberculosis riskTuberculosis casesNational Tuberculosis Surveillance SystemTuberculosis prevention effortsNew tuberculosis casesLow incidence rateTuberculosis Surveillance SystemBirth countryTuberculosis incidenceRisk ratioTuberculosis trendsHigh-income countriesYounger agePrevention effortsEffective targetingCohortEntry yearCommunity surveySurveillance systemRegression modelsAgeUnited StatesTracking and predicting U.S. influenza activity with a real-time surveillance network
Leuba SI, Yaesoubi R, Antillon M, Cohen T, Zimmer C. Tracking and predicting U.S. influenza activity with a real-time surveillance network. PLOS Computational Biology 2020, 16: e1008180. PMID: 33137088, PMCID: PMC7707518, DOI: 10.1371/journal.pcbi.1008180.Peer-Reviewed Original ResearchConceptsInfluenza test resultsInfluenza activityU.S. influenza activityPhysician visitsInfluenza trendsInfluenza-like illness activityNational surveillance networkSurveillance networkInfluenza seasonCurrent burdenU.S. CentersIllness activityDisease controlUnited StatesLinear logistic modelVisitsLogistic modelValid estimatesProportion
2018
The impact of migration on tuberculosis in the United States
Menzies NA, Hill AN, Cohen T, Salomon JA. The impact of migration on tuberculosis in the United States. The International Journal Of Tuberculosis And Lung Disease 2018, 22: 1392-1403. PMID: 30606311, PMCID: PMC6353558, DOI: 10.5588/ijtld.17.0185.Peer-Reviewed Original ResearchConceptsTB casesTB burdenHigher tuberculosis ratesNew TB casesLow-incidence settingsEntry yearActive TBTB epidemiologyTB riskIncidence estimatesTuberculosis ratesLifetime casesUnited StatesRiskPopulation residentGreater exposureBurdenNative-born populationPopulationCountry of originTBYearsTuberculosisCasesInfectionProspects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model
Menzies NA, Cohen T, Hill AN, Yaesoubi R, Galer K, Wolf E, Marks SM, Salomon JA. Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal Of Epidemiology 2018, 187: 2011-2020. PMID: 29762657, PMCID: PMC6119121, DOI: 10.1093/aje/kwy094.Peer-Reviewed Original ResearchConceptsTB preventionTB eliminationLatent TB infection (LTBI) screeningTB case detectionHigh-risk populationImportant health benefitsTransmission dynamic modelIncident TBActive TBTuberculosis eliminationInfection testingTB controlTB incidenceEpidemiologic evidenceTB transmissionInfection screeningCase detectionTuberculosis trendsUS populationRisk determinantsHealth benefitsTreatment qualityUnited StatesTreatment activitiesTreatment